Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAPZA2 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-17 |
mRNA | TMPRSS11F | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-12 |
mRNA | WNT8B | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
mRNA | ATP6V0A4 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
mRNA | IL2RA | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
mRNA | TMEM260 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | GAS1 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
mRNA | PRF1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
mRNA | GZMH | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
mRNA | SPACA7 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |